Literature DB >> 14596456

Anti-inflammatory effects of intramammary infusions of glycyrrhizin in lactating cows with mastitis caused by coagulase-negative staphylococci.

Kenzo Kai1, Ken-ichi Komine, Ken-ichi Asai, Toshinobu Kuroishi, Yumiko Komine, Tomoyuki Kozutsumi, Masashi Itagaki, Minoru Ohta, Yasuo Endo, Katsuo Kumagai.   

Abstract

OBJECTIVE: To determine the anti-inflammatory effects of glycyrrhizin (GL) in lactating cows with mastitis attributable to naturally occurring infection with coagulase-negative staphylococci (CNS). ANIMALS: 12 lactating Holstein cows with mastitis attributable to infection with CNS and 2 healthy cows without mastitis. PROCEDURE: Clinical signs, number of bacteria in milk, somatic cell count (SCC) in milk, concentrations of alpha-lactalbumin and lactoferrin in milk, and concentration of histamine in milk were investigated before and after intramammary infusion of GL (6 cows) or antimicrobials (6 cows). Glands of 2 healthy cows were infused with staphylococcal enterotoxin; milk leukocytes were then harvested and incubated with various doses of GL.
RESULTS: In cows infected with CNS that had a low bacterial concentration in milk, infusion of GL alone resulted in significant improvements in swelling, firmness of glands, and number of clots in milk, and it decreased the SCC, but not significantly. Percentage of neutrophils decreased significantly (to < 30%) by 2 days after infusion. Use of lactoferrin as a marker of inflammation in mammary glands revealed a decrease in concentrations, whereas use of alpha-lactalbumin as a marker of recovery for mammary glands revealed significant increases in concentrations in the GL-infused group. Accompanying these anti-inflammatory effects, a decrease in the concentration of histamine in milk was observed in the GL-infused group. Glycyrrhizin decreased histamine production by milk leukocytes in a concentration-dependent manner. CONCLUSIONS AND CLINICAL RELEVANCE: Infusion of GL may regulate intramammary inflammation through modulation of inflammatory mediators such as histamine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596456     DOI: 10.2460/ajvr.2003.64.1213

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

Review 1.  Pharmacological and chemical effects of cigarette additives.

Authors:  Michael Rabinoff; Nicholas Caskey; Anthony Rissling; Candice Park
Journal:  Am J Public Health       Date:  2007-07-31       Impact factor: 9.308

2.  Efficacy of a botanical preparation for the intramammary treatment of clinical mastitis on an organic dairy farm.

Authors:  Pablo Pinedo; Hubert Karreman; Hans Bothe; Juan Velez; Carlos Risco
Journal:  Can Vet J       Date:  2013-05       Impact factor: 1.008

3.  Induction of nitric oxide production mediated by tumor necrosis factor alpha on staphylococcal enterotoxin C-stimulated bovine mammary gland cells.

Authors:  Ken-Ichi Komine; Toshinobu Kuroishi; Yumiko Komine; Kouichi Watanabe; Jin Kobayashi; Takahiro Yamaguchi; Shin-Ichi Kamata; Katsuo Kumagai
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Glycyrrhizin Protects γ-Irradiated Mice from Gut Bacteria-Associated Infectious Complications by Improving miR-222-Associated Gas5 RNA Reduction in Macrophages of the Bacterial Translocation Site.

Authors:  Ichiaki Ito; Bradford D Loucas; Sumihiro Suzuki; Makiko Kobayashi; Fujio Suzuki
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

5.  Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome.

Authors:  Zhiqian Yu; Yuko Ohtaki; Kenzou Kai; Takashi Sasano; Hidetoshi Shimauchi; Takashi Yokochi; Haruhiko Takada; Shunji Sugawara; Katsuo Kumagai; Yasuo Endo
Journal:  Int Immunopharmacol       Date:  2005-03       Impact factor: 4.932

6.  Effect of glycyrrhizin administration followed by symptom-based antimicrobial selection therapy on antimicrobial use in clinical mastitis without systemic symptoms.

Authors:  Tomomi Kurumisawa; Takuya Yagisawa; Yasunori Shinozuka; Kazuhiro Kawai
Journal:  J Vet Med Sci       Date:  2022-07-19       Impact factor: 1.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.